159 related articles for article (PubMed ID: 12817060)
1. Role of angiotensin II in the progression of diabetic nephropathy-therapeutic implications.
Wiecek A; Chudek J; Kokot F
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v16-20. PubMed ID: 12817060
[No Abstract] [Full Text] [Related]
2. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin and its inhibition: a nephrologist point of view.
Kalra V; Agarwal SK; Wani M
J Assoc Physicians India; 2002 Oct; 50():1270-80. PubMed ID: 12568213
[No Abstract] [Full Text] [Related]
4. Treatment of diabetic nephropathy with angiotensin II blockers.
Sonkodi S; Mogyorósi A
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v21-3. PubMed ID: 12817061
[TBL] [Abstract][Full Text] [Related]
5. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
Bilous R
Prim Care Diabetes; 2008 Dec; 2(4):201-2. PubMed ID: 18760685
[No Abstract] [Full Text] [Related]
6. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
Ravid M
Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S410-3. PubMed ID: 19875590
[No Abstract] [Full Text] [Related]
7. Angiotensin blockade in type 2 diabetic renal disease.
Ruilope LM; Luño J
Kidney Int Suppl; 2002 Dec; (82):S61-3. PubMed ID: 12410857
[TBL] [Abstract][Full Text] [Related]
8. [Diabetic nephropathy and ACE inhibitors].
Amann B
Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i83-7. PubMed ID: 16598556
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II (AT(1)) receptor antagonists, diabetes, and nephropathy: do differences between the renal and systemic circulations explain the outcomes observed with ARBs and ACE inhibitors?
Giles TD; Sander GE
Am J Geriatr Cardiol; 2002; 11(1):62-5. PubMed ID: 11773721
[No Abstract] [Full Text] [Related]
10. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
Rossing P; Parving HH; de Zeeuw D
Nephrol Dial Transplant; 2006 Sep; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724
[No Abstract] [Full Text] [Related]
11. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
Wittmann I; Degrell P; Komáromy A; Molnár GA; Wagner Z; Wagner L; Mazák I; Nagy J
Orv Hetil; 2003 Mar; 144(13):613-9. PubMed ID: 12728786
[TBL] [Abstract][Full Text] [Related]
12. Diabetic nephropathy: introduction.
Breyer MD
Semin Nephrol; 2007 Mar; 27(2):129. PubMed ID: 17418681
[No Abstract] [Full Text] [Related]
13. High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy.
Fernández-Juárez G; Villacorta Perez J; Luño Fernández JL; Martinez-Martinez E; Cachofeiro V; Barrio Lucia V; Tato Ribera AM; Mendez Abreu A; Cordon A; Oliva Dominguez JA; Praga Terente M
Nephrology (Carlton); 2017 May; 22(5):354-360. PubMed ID: 27003829
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy.
Kuriyama S; Tomonari H; Abe A; Imasawa T; Hosoya T
Nephron; 2000 Dec; 86(4):529-30. PubMed ID: 11124615
[No Abstract] [Full Text] [Related]
15. Treating diabetic nephropathy: unfinished success is not failure.
Lewis J
Clin J Am Soc Nephrol; 2007 May; 2(3):407-9. PubMed ID: 17699442
[No Abstract] [Full Text] [Related]
16. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial.
Fernandez Juarez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Cachofeiro V; Nieto J; Fernández Vega F; Tato A; Gutierrez E;
Am J Kidney Dis; 2013 Feb; 61(2):211-8. PubMed ID: 22939518
[TBL] [Abstract][Full Text] [Related]
17. Renal effects of dual renin-angiotensin-aldosterone system blockade in patients with diabetic nephropathy.
Dalla Vestra M; Simioni N; Masiero A
Int Urol Nephrol; 2009; 41(1):119-26. PubMed ID: 18958580
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the renin-angiotensin system.
Cheung BM
Hong Kong Med J; 2002 Jun; 8(3):185-91. PubMed ID: 12055364
[TBL] [Abstract][Full Text] [Related]
19. Renin-Angiotensin system blockade for diabetic nephropathy prevention.
Naviglio S; Pirozzi F
Am J Cardiol; 2010 May; 105(10):1505. PubMed ID: 20451706
[No Abstract] [Full Text] [Related]
20. The renin-angiotensin system and diabetic nephropathy.
Gurley SB; Coffman TM
Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
